Clinical Research Directory
Browse clinical research sites, groups, and studies.
Two Doses of Dexmedetomidine as Adjuvent to Bupivacaine in Tap Block
Sponsor: Assiut University
Summary
The aim of this study to determine the optimal dose of dexmedetomidine as an adjuvant to bupivacaine in U.S guided TAP block for preemptive analgesia In patients undergoing lower abdominal cancer surgeries.
Official title: Comparing the Analgesic Effect of Two Different Doses of Dexmedetomidine Added to Bupivacaine in Ultrasound-guided Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgeries; A Randomized Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2025-01
Completion Date
2026-02
Last Updated
2024-10-03
Healthy Volunteers
No
Conditions
Interventions
Dexmedetomidine as adjuvent to bupvacaine in tap block
The analgesic effect of Two different doses of dexmedetomidine as adjuvent to bupivacaine in tap block
Locations (1)
South egypt cancer institute,Assiut University
Asyut, Egypt